Phase I study of continuous mitomycin-C infusion in concomitant radiochemotherapy of primary inoperable advanced head and neck cancer

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 12, 2005, Pages 815-820

  Christiansen, Hans ^a   Hermann, Robert M ^a   Hille, Andrea ^a   Schmidberger, Heinz ^a   Martin, Alexios ^a   Nitsche, Mirko ^a   Hess, Clemens F ^a   Pradier, Olivier ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Continuous infusion; Head and neck cancer; Mitomycin C; Phase I trial; Radiochemotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INFUSION; DRUG SAFETY; DYSPHAGIA; HEAD AND NECK CARCINOMA; HOARSENESS; HUMAN; LEUKOPENIA; MUCOSA INFLAMMATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; XEROSTOMIA;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 27744504122     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0028-x     Document Type: Article

References (41)

1. Adam MF, Gabalski EC, Bloch DA, Oehlert JW, Brown JM, Elsaid AA, Pinto HA, Terris DJ (1999) Tissue oxygen distribution in head and neck cancer patients. Head Neck 21:146-153
2. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, Eliachar I, Strome M, Larto MA (2000) Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88:876-883
3. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92-98
4. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804
5. Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L (2001) Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 23:579-589
6. Budach VG, Dinges S, Haake K, Stuschke M, Stüben G, Sack H, Jahnke KD, Baumann M, Herrmann T, Budach W, Bamberg M, Sauer R, Wust P, Hinkelbein P, Wernecke KD (2000) Accelerated chemoradiation to 70.6 Gy is more effective than accelerated radiation to 77.6 Gy alone - two years results of a German multicentre randomized trial. Int J Radiat Oncol Biol Phys 48:150-151
7. Budach W, Paulsen F, Welz S, Classen J, Scheithauer H, Marini P, Belka C, Bamberg M (2002) Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma. Br J Cancer 86:470-476
8. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086
9. Christiansen H, Hermann RM, Hille A, Weiss E, Nitsche M, Martin A, Hess CF, Pradier O (2004) Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluoruracil and mitomycin-C. Head Neck 26:845-853
10. Cummings B, Keane T, Thomas G, Harwood A, Rider W (1984) Results and toxicity of the treatment of anal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 54:2062-2068
11. Dinges S, Budach V, Stuschke M, Budach W, Boehmer D, Schrader M, Jahnke K, Sack H (1997) Chemo-radiotherapy for locally advanced head and neck cancer - long term results of a phase II trial. Eur J Cancer 33:1152-1155
12. Dobrowsky W, Naude J (2000) Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol 57:119-124
13. El-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847
14. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, Broder GJ (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14:831-838
15. Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M (2003) Docetaxel, cisplatin, and 5-fluoruracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer 97:412-418
16. Haffty BG, Son YH, Papac R, Sasaki CT, Weissberg JB, Fischer D, Rockwell S, Sartorelli AC, Fischer JJ (1997) Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale mitomycin randomized trials. J Clin Oncol 15:268-276
17. Hartmann JT, Harstrick A, Daikeler T, Kollmannsberger C, Muller C, Seeber S, Kanz L, Bokemeyer C (1998) Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer. Anticancer Drugs 9:427-431
18. Hartmann JT, Kanz L, Bokemeyer C (2000) Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma. Anticancer Res 20:1177-1182
19. Hartmann JT, Quietzsch D, Daikeler C, Kollmannsberger C, Mayer F, Kranz L, Bokemeyer C (1999) Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer. Anticancer Drugs 10:729-733
20. Hoffmann W, Belka C, Schmidberger H, Budach W, Bochtler H, Hess CF, Bamberg M (1997) Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer - results from a Phase I trial. Int J Radiat Oncol Biol Phys 38:691-696
21. International Commission on Radiation Units and Measurements (1993) Prescribing, recording and reporting photon beam therapy. ICRU Report No. 50, MP, Bethesda
22. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 58:457-481
23. Karasawa K, Shinoda H, Katsui K, Seki K, Kohno M, Hanyu N, Nasu S, Muramatsu H, Maebayashi K, Mitsuhashi N, Yoshihara T (2002) Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer. Anticancer Res 22:3785-3788
24. Keane TJ, Cummings BJ, ÓSullivan B, Payne D, Rawlinson E, MacKenzie R, Danjoux C, Hodson I (1993) A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluoruracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 25:613-618
25. Keane TJ, Harwood AR, Elhakim T, Rider WD, Cummings BJ, Ginsberg RJ, Cooper JC (1985) Radical radiation therapy with 5-fluoruracil infusion and mitomycin c for oesophageal squamous carcinoma. Radiother Oncol 4:205-210
26. Kies MS, Haraf DJ, Rosen F, Stenson K, List M, Brockstein B, Chung T, Mittal BB, Pelzer H, Portugal L, Rademaker A, Weichselbaum R, Vokes EE (2001) Concomitant infusional paclitaxel and fluoruracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19:1961-1969
27. Ludgate SM, Crandon AJ, Hudosn CN, Walker Q, Langlands AO (1988) Synchronous 5-fluoruracil, mitomycin c and radiation therapy in the treatment of locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 15:893-899
28. Million RR, Cassisi NJ (1994) Management of head and neck cancer - a multidisciplinary approach, 2nd edn. Lippincott Williams & Wilkens, Philadelphia
29. Moulder JE, Rockwell S (1987) Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev 5:313-341
30. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data MACH-NC Collaborative Group Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949-955
31. Pradier O, Eberlein K, Weiss E, Jackel MC, Hess CF (2001) Radiotherapy combined with simultaneous chemotherapy with mitomycin-C and 5-fluoruracil for inoperable head and neck cancer. Br J Radiol 74:368-374
32. Pradier O, Schmidberger H, Jaeckel M, Florez R, Christiansen H, Steiner W, Hess CF (2002) Adiuvant radiotherapy after transoral microlasersurgery for advanced primary and recurrent squamous cell carcinoma of the head and neck: results of comparative analysis. Radiother Oncol 64:S239
33. Rockwell S (1992) Use of hypoxia-directed drugs in the therapy of solid tumors. Semin Oncol 19:29-40
34. Rubin P, Constine LS III, Fajardo LF, Phillips TL, Wasserman TH (1995) EORTC Late Effects Working Group Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35:9-10
35. Sartorelli AC, Hodnick WF, Belcourt MF, Tomasz M, Haffty B, Fischer JJ, Rockwell S (1994) Mitomycin C: a prototype bioreductive agent. Oncol Res 6:501-508
36. Seifert P, Baker LH, Reed ML, Vaitkevicius VK (1975) Comparison of continuously infused 5-fluoruracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer 36:123-128
37. Smid L, Lesnicar H, Zakotnik B, Soba E, Budihna M, Furlan L, Zargi M, Rudolf Z (1995) Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer - preliminary report. Int J Radiat Oncol Biol Phys 32:769-775
38. Staar S, Rudat V, Stuetzner H, Dietz A, Volling P, Schroeder M, Flentje M, Eckel HE, Mueller RP (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:1161-1171
39. Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47:1-12
40. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Richt T, Shipley W, Curran W (2000) Common toxicity criteria: Version 2.0 an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13-47
41. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16:1318-1324